Dr. Caicun Zhou
Claim this profileShanghai Pulmonary Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
10 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
EGFR positive
2Non-Small Cell Lung Cancer
Stage III
Stage IV
EGFR positive
Clinical Trials Caicun Zhou is currently running
CS5001
for Advanced Cancers
This trial is testing a new drug called CS5001 to see if it is safe and effective for patients with advanced blood-related and solid cancers. The drug aims to attack and stop the growth of cancer cells.
Recruiting1 award Phase 110 criteria
DZD9008 vs Chemotherapy
for Lung Cancer
This is a phase 3, open-label, randomized, multi-center study assessing the efficacy and safety of DZD9008 versus platinum-based doublet chemotherapy in participants with locally advanced or metastatic NSCLC with EGFR Exon20ins mutation, who are newly diagnosed or have not received prior systemic therapy in advanced stage. Primary objective of this study is to assess the efficacy of DZD9008 versus platinum-based doublet chemotherapy using by BICR-assessed PFS per RECIST 1.1 as primary endpoint. Approximately 320 participants are estimated to be randomized into the study. Participants enrolled will be randomized to DZD9008 or platinum-based doublet chemotherapy in a 1:1 manner, stratified by baseline brain metastasis (with/without).
Recruiting2 awards Phase 33 criteria
More about Caicun Zhou
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Caicun Zhou has experience with
- DZD9008
- Pemetrexed+carboplatin
- Selpercatinib
- GQ1001
- Camrelizumab
- Famitinib Malate
Breakdown of trials Caicun Zhou has run
Lung Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Caicun Zhou specialize in?
Caicun Zhou focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Caicun Zhou currently recruiting for clinical trials?
Yes, Caicun Zhou is currently recruiting for 3 clinical trials in Shanghai Shanghai. If you're interested in participating, you should apply.
Are there any treatments that Caicun Zhou has studied deeply?
Yes, Caicun Zhou has studied treatments such as DZD9008, Pemetrexed+carboplatin, Selpercatinib.
What is the best way to schedule an appointment with Caicun Zhou?
Apply for one of the trials that Caicun Zhou is conducting.
What is the office address of Caicun Zhou?
The office of Caicun Zhou is located at: Shanghai Pulmonary Hospital, Shanghai, Shanghai 200433 China. This is the address for their practice at the Shanghai Pulmonary Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.